Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
Antares Therapeutics has raised $177.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Antares Therapeutics's investors include Lightspeed Venture Partners, Cormorant Asset Management, Abingworth, Omega Funds, Vida Ventures.
Antares Therapeutics is headquartered in Boston, United States.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
Antares Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Antares Therapeutics — Funding & Investors." VCBacked, May 15, 2025, https://www.vcbacked.co/company/antares-therapeutics. Accessed September 2, 2026.
VCBacked. (2025). Antares Therapeutics — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/antares-therapeutics
{{cite web |title=Antares Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/antares-therapeutics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated